Ma D - Search Results

1

Capsaicin reduces Alzheimer-associated tau changes in the hippocampus of type 2 diabetes rats.

Xu W, Liu J, Ma D, Yuan G, Lu Y, Yang Y. Xu W, et al. Among authors: ma d. PLoS One. 2017 Feb 22;12(2):e0172477. doi: 10.1371/journal.pone.0172477. eCollection 2017. PLoS One. 2017. PMID: 28225806 Free PMC article.

2

Intranasal insulin ameliorates tau hyperphosphorylation in a rat model of type 2 diabetes.

Yang Y, Ma D, Wang Y, Jiang T, Hu S, Zhang M, Yu X, Gong CX. Yang Y, et al. Among authors: ma d. J Alzheimers Dis. 2013;33(2):329-38. doi: 10.3233/JAD-2012-121294. J Alzheimers Dis. 2013. PMID: 22936005

3

Subcutaneous administration of liraglutide ameliorates Alzheimer-associated tau hyperphosphorylation in rats with type 2 diabetes.

Yang Y, Zhang J, Ma D, Zhang M, Hu S, Shao S, Gong CX. Yang Y, et al. Among authors: ma d. J Alzheimers Dis. 2013;37(3):637-48. doi: 10.3233/JAD-130491. J Alzheimers Dis. 2013. PMID: 23948890

4

Short-term effects of continuous subcutaneous insulin infusion therapy in perioperative patients with diabetes mellitus.

Ma D, Chen C, Lu Y, Ma J, Yin P, Xie J, Yang Y, Shao S, Liu Z, Zhou X, Yuan G, Yu X. Ma D, et al. Among authors: ma j. Diabetes Technol Ther. 2013 Dec;15(12):1010-8. doi: 10.1089/dia.2013.0117. Epub 2013 Aug 24. Diabetes Technol Ther. 2013. PMID: 23971526 Free PMC article.

5

The changes of leukocyte telomere length and telomerase activity after sitagliptin intervention in newly diagnosed type 2 diabetes.

Ma D, Yu Y, Yu X, Zhang M, Yang Y. Ma D, et al. Diabetes Metab Res Rev. 2015 Mar;31(3):256-61. doi: 10.1002/dmrr.2578. Epub 2014 Sep 2. Diabetes Metab Res Rev. 2015. PMID: 25044768 Clinical Trial.

6

Exendin-4, a glucagon-like peptide-1 receptor agonist, reduces Alzheimer disease-associated tau hyperphosphorylation in the hippocampus of rats with type 2 diabetes.

Xu W, Yang Y, Yuan G, Zhu W, Ma D, Hu S. Xu W, et al. Among authors: ma d. J Investig Med. 2015 Feb;63(2):267-72. doi: 10.1097/JIM.0000000000000129. J Investig Med. 2015. PMID: 25479064

7

Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis.

Lu Y, Ma D, Xu W, Shao S, Yu X. Lu Y, et al. Among authors: ma d. J Diabetes Investig. 2015 Jan;6(1):78-86. doi: 10.1111/jdi.12246. Epub 2014 Jun 18. J Diabetes Investig. 2015. PMID: 25621136 Free PMC article.

8

Early intervention with glucagon-like peptide 1 analog liraglutide prevents tau hyperphosphorylation in diabetic db/db mice.

Ma DL, Chen FQ, Xu WJ, Yue WZ, Yuan G, Yang Y. Ma DL, et al. J Neurochem. 2015 Oct;135(2):301-8. doi: 10.1111/jnc.13248. Epub 2015 Aug 11. J Neurochem. 2015. PMID: 26183127 Free article.

9

Exendin-4 reduces tau hyperphosphorylation in type 2 diabetic rats via increasing brain insulin level.

Yang Y, Ma D, Xu W, Chen F, Du T, Yue W, Shao S, Yuan G. Yang Y, et al. Among authors: ma d. Mol Cell Neurosci. 2016 Jan;70:68-75. doi: 10.1016/j.mcn.2015.10.005. Epub 2015 Nov 27. Mol Cell Neurosci. 2016. PMID: 26640240

10

Exendin-4 reduces food intake via the PI3K/AKT signaling pathway in the hypothalamus.

Yang Y, Choi PP, Smith WW, Xu W, Ma D, Cordner ZA, Liang NC, Moran TH. Yang Y, et al. Among authors: ma d. Sci Rep. 2017 Jul 31;7(1):6936. doi: 10.1038/s41598-017-06951-0. Sci Rep. 2017. PMID: 28761132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,764 results

Search Page

Filters